Skip to main content

Table 2 Characteristics of the study population

From: Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7

 

Total CHD population

(n = 1483)

MI

(n = 753)

PCI and/or CABG, but no MI

(n = 604)

AP, but no MI, PCI or CABG

(n = 126)

Sex, n (%)

        

 Women

446

(30.1)

174

(23.1)

203

(33.6)

69

(54.8)

Age, mean (sd)

68.7

(10.8)

69.2

(10.1)

69.2

(10.6)

63.0

(13.7)

Smoking, n (%)

        

 Daily smoking

182

(12.3)

96

(12.7)

67

(11.1)

19

(15.1)

 Smoked previously

860

(58.0)

472

(62.7)

334

(55.3)

54

(42.9)

Self-reported health, n (%)

        

 Excellent/good

705

(47.5)

343

(45.6)

311

(51.5)

51

(40.5)

 Neither good nor bad

602

(40.6)

318

(42.2)

232

(38.4)

52

(41.3)

 Bad/very bad

153

(10.3)

79

(10.5)

53

(8.8)

21

(16.7)

Comorbidities*, n (%)

        

 Hypertension

827

(55.8)

433

(57.5)

328

(54.3)

66

(52.4)

 Heart failure

231

(15.6)

126

(16.7)

94

(15.6)

11

(8.7)

 Atrial fibrillation

283

(19.1)

138

(18.3)

111

(18.4)

34

(27.0)

 Stroke

123

(8.3)

65

(8.6)

49

(8.1)

9

(7.1)

 Diabetes

214

(14.4)

123

(16.3)

80

(13.2)

11

(8.7)

 Renal disease

114

(7.7)

68

(9.0)

35

(5.6)

11

(8.7)

 Cancer

189

(12.7)

101

(13.4)

77

(12.7)

11

(8.7)

Medications, mean number of products (sd)

4.0

(2.9)

4.3

(3.0)

3.8

(2.8)

3.0

(2.9)

Clinical measurements, mean (sd)

 Systolic blood pressure, mmHg

136

(20.9)

135

(21.7)

137

(19.9)

133

(20.3)

 Diastolic blood pressure, mmHg

74

(9.9)

75

(10.0)

74

(9.6)

76

(10.1)

 Total cholesterol, mmol/l

4.6

(1.1)

4.5

(1.1)

4.7

(1.1)

5.6

(1.3)

 LDL-cholesterol, mmol/l

2.9

(1.0)

2.7

(1.0)

2.9

(1.0)

3.7

(1.2)

 HDL-cholesterol, mmol/l

1.4

(0.4)

1.4

(0.4)

1.5

(0.5)

1.5

(0.4)

 Triglycerides, mmol/l

1.6

(1.0)

1.7

(1.0)

1.5

(0.8)

1.8

(0.9)

 HbA1c, %

6.1

(0.9)

6.1

(1.0)

6.0

(0.8)

5.8

(0.5)

 Glucose, mmol/l§

6.0

(2.1)

6.2

(2.3)

6.0

(1.9)

5.6

(1.3)

 BMI, kg/m2

28.4

(4.5)

28.5

(4.4)

28.1

(4.4)

28.7

(5.2)

  1. AP, angina pectoris; BMI, body mass index; CABG, coronary artery bypass graft; CHD, coronary heart disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; PCI, percutaneous coronary intervention; sd, standard deviation
  2. *Self-reported relevant comorbidities for coronary heart disease, present or previous diseases. For diabetes: present disease or use of any antidiabetic drug
  3. To convert to mg/dL, multiply with 38.67
  4. To convert to mg/dL, multiply with 88.57
  5. §To convert to mg/dL, multiply with 18.02